Generative AI can be used as a conversational expert to quickly gain deep domain knowledge in new industries. By engaging in long dialogues about market trends, regulations, and business models (e.g., value-based medicine), a leader can compress months of research into a single afternoon.

Dr. Anna Persaud advises founders to "use what you've got." She leveraged her background as a PhD biochemist to establish academic research partnerships and build a brand rooted in scientific proof. This personal expertise became a key differentiator and a source of authentic authority in a crowded market.

David Epstein's book *Range* shows that breakthrough innovators often switch disciplines. By entering a new field "through the side door," they bring different mental models and "far analogies" that allow them to see solutions incumbents cannot.

Dr. Vibha Jawa's career shows a powerful strategy: learning drug development fundamentals in large companies (Amgen, Merck) and applying them in nimble startups. This cycle across different environments accelerates learning and deepens expertise in a specialized field like immunogenicity.

A leader in a highly technical field doesn't need to be the deepest scientific expert. Venture capitalist Jeanne Cunicelli, who is not a scientist, succeeds by mastering the skill of deconstructing complex topics through persistent questioning and listening, enabling her to make sound judgments.

The core job of a scientist isn't knowing facts, but figuring out what's unknown. This problem-solving 'toolbox'—how to think, act, and work with teams to tackle new problems—is directly transferable to the CEO role, enabling leaders to navigate unfamiliar domains like corporate finance or legal structures.

The speaker faced two simultaneous crises: his son's cancer and a basement flood. AI was able to bridge the knowledge gap between oncology (immunosuppression risks) and mold remediation (air quality management), providing a synthesized, actionable plan that no single human expert could realistically offer.

R&D leaders can work across diverse fields like immunology and dermatology by mastering fundamental principles. Skills like effective clinical trial design and objective, data-driven decision-making are universal, allowing an expert to pivot and add value in any new therapeutic area.

After his Oculus exit, Antonov didn't just write checks. He took university extension classes and attended conferences for years to deeply understand biology's complexities. This demonstrates a patient, knowledge-first approach for domain-switching entrepreneurs.